Delafloxacin meglumineProduct ingredient for Delafloxacin

Name
Delafloxacin meglumine
Drug Entry
Delafloxacin

Delafloxacin is a fluoroquinolone antibiotic which has been used in trials studying the treatment and basic science of Gonorrhea, Hepatic Impairment, Bacterial Skin Diseases, Skin Structure Infections, and Community Acquired Pneumonia, among others. It was approved in June 2017 under the trade name Baxdela for use in the treatment of acute bacterial skin and skin structure infections.

Accession Number
DBSALT002486
Structure
Synonyms
Not Available